NASDAQ:KNSY - Kensey Nash Stock Price, Price Target & More

Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Kensey Nash (NASDAQ:KNSY)

Kensey Nash logoKensey Nash Corporation is a medical device company primarily focused in the field of regenerative medicine, which is the application of devices, materials and other therapies to help repair damaged or diseased tissues. The Company has a range of products, which are sold through strategic partners in multiple large medical markets, including cardiology, orthopaedic, sports medicine, spinal and general surgery. It also has an ongoing development and manufacturing program for products in the endovascular market. During the fiscal year ended June 30, 2010 (fiscal 2010), the Company manufactured and sold over 4.5 million resorbable product units representing approximately 230 commercialized products, to strategic partners and customers. In January 2011, the Company acquired Nerites Corporation. In June 2012, Koninklijke DSM NV acquired the Company.

Receive KNSY News and Ratings via Email

Sign-up to receive the latest news and ratings for KNSY and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolNASDAQ:KNSY
CUSIPN/A
Phone+1-484-7132100

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A

How to Become a New Pot Stock Millionaire

Kensey Nash (NASDAQ:KNSY) Frequently Asked Questions

What is Kensey Nash's stock symbol?

Kensey Nash trades on the NASDAQ under the ticker symbol "KNSY."

Has Kensey Nash been receiving favorable news coverage?

News coverage about KNSY stock has trended somewhat positive on Wednesday, Accern reports. Accern rates the sentiment of press coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Kensey Nash earned a coverage optimism score of 0.05 on Accern's scale. They also assigned press coverage about the medical device company an impact score of 47.60 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the next several days.

How do I buy shares of Kensey Nash?

Shares of KNSY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact Kensey Nash?

Kensey Nash's mailing address is 735 Pennsylvania Drive, EXTON, PA 19341, United States. The medical device company can be reached via phone at +1-484-7132100.


MarketBeat Community Rating for Kensey Nash (KNSY)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  37 (Vote Outperform)
Underperform Votes:  51 (Vote Underperform)
Total Votes:  88
MarketBeat's community ratings are surveys of what our community members think about Kensey Nash and other stocks. Vote "Outperform" if you believe KNSY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe KNSY will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Kensey Nash (NASDAQ:KNSY) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
(Data available from 4/25/2016 forward)

Earnings

Kensey Nash (NASDAQ:KNSY) Earnings History and Estimates Chart

Earnings by Quarter for Kensey Nash (NASDAQ:KNSY)

Kensey Nash (NASDAQ KNSY) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/3/2012$0.35$0.34ViewN/AView Earnings Details
2/2/2012$0.46$0.51ViewN/AView Earnings Details
10/20/2011$0.31$0.32ViewN/AView Earnings Details
8/18/2011$0.34$0.34ViewN/AView Earnings Details
5/5/2011$0.42$0.43ViewN/AView Earnings Details
2/1/2011$0.39$0.38ViewN/AView Earnings Details
10/21/2010Q1 2011$0.42$0.41ViewN/AView Earnings Details
8/23/2010Q4 2010$0.51$0.54ViewN/AView Earnings Details
4/22/2010Q3 2010$0.45$0.46ViewN/AView Earnings Details
1/28/2010Q2 2010$0.38$0.43ViewN/AView Earnings Details
10/22/2009Q1 2010$0.40$0.43ViewN/AView Earnings Details
8/20/2009Q4 2009$0.38$0.41ViewN/AView Earnings Details
4/22/2009Q3 2009$0.40$0.42ViewN/AView Earnings Details
1/28/2009Q2 2009$0.40$0.44ViewN/AView Earnings Details
10/23/2008Q1 2009$0.35$0.43ViewN/AView Earnings Details
8/21/2008Q4 2008$0.32$0.35ViewN/AView Earnings Details
4/29/2008Q3 2008$0.25$0.28ViewN/AView Earnings Details
1/25/2008Q2 2008$0.19$0.21ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Kensey Nash (NASDAQ:KNSY) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Kensey Nash (NASDAQ KNSY) Insider Trading and Institutional Ownership History

Insider Trading History for Kensey Nash (NASDAQ:KNSY)

Kensey Nash (NASDAQ KNSY) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
(Data available from 1/1/2013 forward)

Headlines

Kensey Nash (NASDAQ KNSY) News Headlines

Source:
No headlines for this company have been tracked by MarketBeat.com

SEC Filings

Kensey Nash (NASDAQ:KNSY) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Kensey Nash (NASDAQ:KNSY) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Kensey Nash (NASDAQ KNSY) Stock Chart for Wednesday, April, 25, 2018

Loading chart…

This page was last updated on 4/25/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.